2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide,
RO 4929097,
RO-4929097,
RO4929097,
RO4929097,
847925-91-1,
RO-4929097,
Ro 4929097,
UNII-KK8645V7LE,
KK8645V7LE,
RG-4733,
R-4733,
N1-[(7S)-6,7-dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)propanediamide,
(S)-2,2-dimethyl-N1-(6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N3-(2,2,3,3,3-pentafluoropropyl)malonamide,
n1-((7s)-6,7-dihydro-6-oxo-5h-dibenz(b,d)azepin-7-yl)-2,2-dimethyl-n3-(2,2,3,3,3-pentafluoropropyl)propanediamide,
OJPLJFIFUQPSJR-INIZCTEOSA-N,
cc-19,
MLS006011071,
GTPL7338,
SCHEMBL1376366,
CHEBI:86474,
DTXSID20233833,
C22H20F5N3O3,
BCPP000088,
EX-A1750,
ABP000966,
s1575,
ZINC43208642,
CS-0480,
DB11870,
RL05211,
SB16672,
NCGC00263162-01,
NCGC00263162-02,
BC638865,
HY-11102,
SC-85823,
SMR004702861,
X7559,
W-5749,
J-523360,
RO-4929097,RO 4929097, 847925-91-1,
2,2-dimethyl-N(1)-[(7S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-N(3)-(2,2,3,3,3-pentafluoropropyl)propanediamide,
2,2-dimethyl-N-((S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N'-(2,2,3,3,3-pentafluoro-propyl)-malonamide,
2,2-dimethyl-N-[(10S)-9-oxo-8-azatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2(7),3,5,12,14-hexaen-10-yl]-N'-(2,2,3,3,3-pentafluoropropyl)propanediamide,
2,2-dimethyl-N-[(10S)-9-oxo-8-azatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl]-N'-(2,2,3,3,3-pentafluoropropyl)propanediamide,
N1-[(7S)-6,7-Dihydro-6-oxo-5h-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-n3-(2,2,3,3,3-pentafluoropropyl)-propanediamide,
Propanediamide, N-((7S)-6,7-dihydro-6-oxo-5H-dibenz(b,d)azepin-7-yl)-2,2-dimethyl-N'-(2,2,3,3,3-pentafluoropropyl)-,
Propanediamide, N1-[(7S)-6,7-dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl),
D0I3WC,
A4005,
A10802,
RO4929097;RO-4929097,
RO 4929097, 98%, a gamma secretase inhibitor - 25MG 25mg,
Propanediamide, N1-[(7S)-6,7-dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)-,